Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
Type
Guidance (12)
NICE advice (5)
Quality standard (2)
Guidance programme
Guidance programme
Clinical guidelines (2)
Diagnostics guidance (1)
Interventional procedures guidance (1)
NICE guidelines (2)
Technology appraisal guidance (8)
Advice programme
Advice programme
Medtech innovation briefings (5)
Apply filters
Showing 11 to 19 of 19
Sort by
Date
Title
Apply sorting
Last updated date between 1/7/2017 and 31/7/2017
Remove Last updated date between 1/7/2017 and 31/7/2017 filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people
TA455
12 July 2017
12 July 2017
Ustekinumab for moderately to severely active Crohn's disease after previous treatment
TA456
12 July 2017
12 July 2017
New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners
DG3
25 January 2012
6 July 2017
Aquilion PRIME CT scanner for imaging coronary artery disease in adults in whom imaging is difficult
MIB53
1 March 2016
6 July 2017
Somatom Definition Edge CT scanner for imaging coronary artery disease in adults in whom imaging is difficult
MIB54
1 March 2016
6 July 2017
Ibrutinib for untreated chronic lymphocytic leukaemia without a 17p deletion or TP53 mutation (terminated appraisal)
TA452
5 July 2017
5 July 2017
Bortezomib for treating multiple myeloma after second or subsequent relapse (terminated appraisal)
TA453
5 July 2017
5 July 2017
Daratumumab with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)
TA454
5 July 2017
5 July 2017
L-Dex U400 for lymphoedema after breast cancer treatment
MIB111
4 July 2017
4 July 2017
Previous page
1
Current page
2
Page
2
of
2
Results per page
10
25
50
All
Back to top